文献速递外周动脉疾病

商业保险非医保人群中间歇性跛行的治疗模式

Intermittent claudication treatment patterns in the commercially insured non-Medicare population.
PubMed 文献 · J Vasc Surg · 2021-02-04

本研究基于IBM MarketScan商业保险数据库,分析2007至2016年新诊断间歇性跛行(IC)患者的治疗模式。在300,590例患者中,他汀使用率低(诊断时48%,1年后52%),14.3%接受干预,诊断至干预时间从2008年230天缩短至2016年49天,门诊环境下斑块旋切术使用增加。

要点

  • 商业保险IC患者他汀使用率低,诊断时仅48%。
  • 诊断至干预时间显著缩短,从2008年230天降至2016年49天。
  • 门诊斑块旋切术比例从2007年9.7%增至2016年29%。

核心结论

  • 年轻商业保险IC患者干预时间缩短,多次干预常见,他汀使用率低。
  • 门诊手术尤其是办公室/手术中心越来越多使用斑块旋切术,住院环境未观察到此趋势。

研究设计与样本

  • 纳入2007至2016年新诊断IC患者300,590例,平均保险覆盖4.4年,中位年龄58岁,56%男性。

主要发现

  • 14.3%的患者接受干预,其中20%接受≥2次干预,6%接受≥3次干预。
  • 诊断至干预中位时间从2008年230天降至2016年49天(R2=0.98)。
  • 门诊干预中7.9%在办公室/手术中心进行;门诊斑块旋切术比例从2007年9.7%升至2016年29%(R2=0.94)。
  • 2016年办公室/手术中心IC干预中57.6%使用斑块旋切术;门诊斑块旋切术由心脏科医生占22.6%、外科医生15.2%、放射科医生13.6%。
  • 住院斑块旋切率稳定;开放和血管内胫动脉干预分别占门诊和住院IC干预的7.9%和7.8%;胫动脉旁路占所有开放IC干预的8.2%。

临床怎么用

  • 对商业保险IC患者应加强他汀类药物处方以符合指南。
  • 关注门诊斑块旋切术使用增加的趋势,评估其合理性和 outcomes。
  • 了解干预时间缩短和多次干预的模式,优化治疗决策。

局限性

  • 仅基于商业保险索赔数据,可能不适用于无保险或医保人群。
  • 回顾性设计,依赖编码准确性,缺乏临床细节和结局数据。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: Despite published guidelines and data for Medicare patients, it is uncertain how younger patients with intermittent claudication (IC) are treated. Additionally, the degree to which treatment patterns have changed over time with the expansion of endovascular interventions and outpatient centers is unclear. Our goal was to characterize IC treatment patterns in the commercially insured non-Medicare population. METHODS: The IBM MarketScan Commercial Database, which includes more than 8 billion US commercial insurance claims, was queried for patients newly diagnosed with IC from 2007 to 2016. Patient demographics, medication profiles, and open/endovascular interventions were evaluated. Time trends were modeled using simple linear regression and goodness-of-fit was assessed with coefficients of determination (R2). A patient-centered cohort sample and a procedure-focused dataset were analyzed. RESULTS: Among 152,935,013 unique patients in the database, there were 300,590 patients newly diagnosed with IC. The mean insurance coverage was 4.4 years. The median patients age was 58 years and 56% of patients were male. The prevalence of statin use was 48% among patients at the time of IC diagnosis and increased to 52% among patients after one year from diagnosis. Interventions were performed in 14.3%, of whom 20% and 6% underwent two or more and three or more interventions, respectively. The median time from diagnosis to intervention decreased from 230 days in 2008 days to 49 days in 2016 (R2 = 0.98). There were 16,406 inpatient and 102,925 ambulatory interventions for IC over the study period. Among ambulatory interventions, 7.9% were performed in office-based/surgical centers. The proportion of atherectomies performed in the ambulatory setting increased from 9.7% in 2007 to 29% in 2016 (R2 = 0.94). In office-based/surgical centers, 57.6% of interventions for IC used atherectomy in 2016. Atherectomy was used in ambulatory interventions by cardiologists in 22.6%, surgeons in 15.2%, and radiologists in 13.6% of interventions. Inpatient atherectomy rates remained stable over the study period. Open and endovascular tibial interventions were performed in 7.9% and 7.8% of ambulatory and inpatient IC interventions, respectively. Tibial bypasses were performed in 8.2% of all open IC interventions. CONCLUSIONS: There has been shorter time to intervention in the treatment of younger, commercially insured patients with IC, with many receiving multiple interventions. Statin use was low. Ambulatory procedures, especially in office-based/surgical centers, increasingly used atherectomy, which was not observed in inpatient settings.

来源:J Vasc Surg,查看原文。版权归原作者所有。

引用

  1. Siracuse JJ, Woodson J, Ellis RP, et al. Intermittent claudication treatment patterns in the commercially insured non-Medicare population. J Vasc Surg. 2021. PMID: 33548437. doi:10.1016/j.jvs.2020.10.090

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。